Macrolide antibiotics and the airway: antibiotic or non-antibiotic effects?

Bibliography

• Retsema J, Fu W. Macrolides: structures and microbial targets. Int J Antimicrob Agents 2001;18(Suppl 1):S3-10
   PubMed Web of Science ®Google Scholar
• Katz L, Ashley GW. Translation and protein synthesis: macrolides. Chem Rev 2005;105(2):499-528
   PubMed Web of Science ®Google Scholar
• Bosnar M, Kelneric Z, Munic V, Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 2005;49(6):2372-7
   PubMed Web of Science ®Google Scholar
• Zuckerman JM. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am 2004;18(3):621-49
   PubMed Web of Science ®Google Scholar
• Wilms EB, Touw DJ, Heijerman HG. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. Ther Drug Monit 2006;28(2):219-25
   PubMed Web of Science ®Google Scholar
• Scaglione F, Rossoni G. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. J Antimicrob Chemother 1998;41(Suppl B):47-50
   PubMedGoogle Scholar
• Ishimoto H, Mukae H, Sakamoto N, Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. J Antimicrob Chemother 2009;63(1):109-14
   PubMed Web of Science ®Google Scholar
• Homma H, Yamanaka A, Tanimoto S, Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 1983;83(1):63-9
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Saiki S, Tamura S, Saito K. Problems in chronic obstructive bronchial diseases, with special reference to diffuse panbronchiolitis. Naika 1969;23(3):442-51
   PubMedGoogle Scholar
• Kudoh S, Keicho N. Diffuse panbronchiolitis. Semin Respir Crit Care Med 2003;24(5):607-18
   PubMed Web of Science ®Google Scholar
• Poletti V, Casoni G, Chilosi M, Zompatori M. Diffuse panbronchiolitis. Eur Respir J 2006;28(4):862-71
   PubMed Web of Science ®Google Scholar
• Miyashita N, Matsumoto A, Kubota Y, Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis. Microbiol Immunol 1996;40(8):547-52
   PubMed Web of Science ®Google Scholar
• Miyashita N, Niki Y, Nakajima M, Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest 1998;114(4):969-71
   PubMed Web of Science ®Google Scholar
• Kudoh S, Azuma A, Yamamoto M, Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998;157(6 Pt 1):1829-32
   PubMed Web of Science ®Google Scholar
• Fujii T, Kadota J, Kawakami K, Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 1995;50(12):1246-52
   PubMed Web of Science ®Google Scholar
• Kadota J, Mukae H, Ishii H, Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respir Med 2003;97(7):844-50
   PubMed Web of Science ®Google Scholar
• Nagai H, Shishido H, Yoneda R, Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991;58(3-4):145-9
   PubMed Web of Science ®Google Scholar
• Nakamura H, Fujishima S, Inoue T, Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection. Eur Respir J 1999;13(6):1371-9
   PubMed Web of Science ®Google Scholar
• Hoiby N. Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax 1994;49(6):531-2
   PubMed Web of Science ®Google Scholar
• Everard ML, Sly P, Brenan S, Ryan G. Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis. Eur Respir J 1997;10(12):2926
   PubMed Web of Science ®Google Scholar
• Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998;351(9100):420
   PubMed Web of Science ®Google Scholar
• Wolter J, Seeney S, Bell S, Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 2002;57(3):212-6
   PubMed Web of Science ®Google Scholar
• Equi A, Balfour-Lynn IM, Bush A, Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002;360(9338):978-84
   PubMed Web of Science ®Google Scholar
• Saiman L, Marshall BC, Mayer-Hamblett N, Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003;290(13):1749-56
   PubMed Web of Science ®Google Scholar
• Saiman L, Mayer-Hamblett N, Campbell P, Marshall BC. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;172(8):1008-12
   PubMed Web of Science ®Google Scholar
• Clement A, Tamalet A, Leroux E, Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial. Thorax 2006;61(10):895-902
   PubMed Web of Science ®Google Scholar
• Southern KW, Barker PM, Solis A. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2004;(2):CD002203
   Google Scholar
• Flume PA, O'Sullivan BP, Robinson KA, Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007;176(10):957-69
   PubMed Web of Science ®Google Scholar
• Steinkamp G, Schmitt-Grohe S, Doring G, Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection. Respir Med 2008;102(11):1643-53
   PubMed Web of Science ®Google Scholar
• Tsang KW, Ho PI, Chan KN, A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J 1999;13(2):361-4
   PubMed Web of Science ®Google Scholar
• Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax 2004;59(6):540-1
   PubMed Web of Science ®Google Scholar
• Koh YY, Lee MH, Sun YH, Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J 1997;10(5):994-9
   PubMed Web of Science ®Google Scholar
• Anwar GA, Bourke SC, Afolabi G, Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med 2008;102(10):1494-6
   PubMed Web of Science ®Google Scholar
• Gerhardt SG, McDyer JF, Girgis RE, Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003;168(1):121-5
   PubMed Web of Science ®Google Scholar
• Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004;77(9):1465-7
   PubMed Web of Science ®Google Scholar
• Yates B, Murphy DM, Forrest IA, Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005;172(6):772-5
   PubMed Web of Science ®Google Scholar
• Shitrit D, Bendayan D, Gidon S, Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 2005;24(9):1440-3
   PubMed Web of Science ®Google Scholar
• Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006;174(5):566-70
   PubMed Web of Science ®Google Scholar
• Gottlieb J, Szangolies J, Koehnlein T, Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008;85(1):36-41
   PubMed Web of Science ®Google Scholar
• Vanaudenaerde BM, Meyts I, Vos R, A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 2008;32(4):832-43
   PubMed Web of Science ®Google Scholar
• Garey KW, Rubinstein I, Gotfried MH, Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. Chest 2000;118(6):1826-7
   PubMed Web of Science ®Google Scholar
• Hahn DL. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol 1999;83(4):271-88, 91; quiz 91-2
   PubMed Web of Science ®Google Scholar
• Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005;172(9):1078-89
   PubMed Web of Science ®Google Scholar
• Black PN, Blasi F, Jenkins CR, Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001;164(4):536-41
   PubMed Web of Science ®Google Scholar
• Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002;121(6):1782-8
   PubMed Web of Science ®Google Scholar
• Simpson JL, Powell H, Boyle MJ, Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008;177(2):148-55
   PubMed Web of Science ®Google Scholar
• Johnston SL, Blasi F, Black PN, The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006;354(15):1589-600
   PubMed Web of Science ®Google Scholar
• Hahn DL, Plane MB, Mahdi OS, Byrne GI. Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma. PLoS Clin Trials 2006;1(2):e11
   PubMedGoogle Scholar
• Cherniack NS, Vosti KL, Dowling HF, Long-term treatment of bronchlectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycinpenicillin mixture. AMA Arch Intern Med 1959;103(3):345-53
   PubMedGoogle Scholar
• Edwards G, Fear EC. Adult chronic bronchitis: continuous antibiotic therapy. Br Med J 1958;2(5102):1010-2
   PubMed Web of Science ®Google Scholar
• Elmes PC, Fletcher CM, Dutton AA. Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis. Br Med J 1957;2(5056):1272-5
   PubMed Web of Science ®Google Scholar
• Johnston RN, McNeill RS, Smith DH, Five-year winter chemoprophylaxis for chronic bronchitis. Br Med J 1969;4(5678):265-9
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Niewoehner DE. Antibiotic prophylaxis for chronic obstructive pulmonary disease: resurrecting an old idea. Am J Respir Crit Care Med 2008;178(11):1098-9
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Kobayashi D, Asano Y, Clarithromycin prevents smoke-induced emphysema in mice. Am J Respir Crit Care Med 2009;179(4):271-8
   PubMed Web of Science ®Google Scholar
• Blasi F, Damato S, Cosentini R, Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002;57(8):672-6
   PubMed Web of Science ®Google Scholar
• Wu L, Skinner SJ, Lambie N, Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(3 Pt 1):1148-51
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Wilkinson TM, Hurst JR, Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008;178(11):1139-47
   PubMed Web of Science ®Google Scholar
• Hirata T, Ogawa E, Takenaka K, Kawashita F. Suppression of postoperative systemic inflammatory response syndrome with clarithromycin following lung cancer surgery. Eur Surg Res 2004;36(1):13-9
   PubMed Web of Science ®Google Scholar
• Mikasa K, Sawaki M, Kita E, Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin. Chemotherapy 1997;43(4):288-96
   PubMed Web of Science ®Google Scholar
• Sauter C, Blum S. Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease. Am J Clin Oncol 2003;26(1):92-4
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Pechere JC, Routsi C, Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 2008;46(8):1157-64
   PubMed Web of Science ®Google Scholar
• Knyazhitskiy A, Masson RG, Corkey R, Joiner J. Beneficial response to macrolide antibiotic in a patient with desquamative interstitial pneumonia refractory to corticosteroid therapy. Chest 2008;134(1):185-7
   PubMed Web of Science ®Google Scholar
• Restrepo MI, Mortensen EM, Waterer GW, Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Respir J 2009;33(1):153-9
   PubMed Web of Science ®Google Scholar
• Stover DE, Mangino D. Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia? Chest 2005;128(5):3611-7
   PubMed Web of Science ®Google Scholar
• Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J 2007;29(1):91-7
   PubMed Web of Science ®Google Scholar
• Khalid M, Al Saghir A, Saleemi S, Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 2005;25(3):490-3
   PubMed Web of Science ®Google Scholar
• Glanville AR, Gencay M, Tamm M, Chlamydia pneumoniae infection after lung transplantation. J Heart Lung Transplant 2005;24(2):131-6
   PubMed Web of Science ®Google Scholar
• Kotsimbos TC, Snell GI, Levvey B, Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2005;79(3):269-75
   PubMed Web of Science ®Google Scholar
• Gass R, Fisher J, Badesch D, Donor-to-host transmission of Mycoplasma hominis in lung allograft recipients. Clin Infect Dis 1996;22(3):567-8
   PubMed Web of Science ®Google Scholar
• Martin RJ, Kraft M, Chu HW, A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001;107(4):595-601
   PubMed Web of Science ®Google Scholar
• Chu HW, Rino JG, Wexler RB, Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol 2005;289(1):L125-33
   PubMed Web of Science ®Google Scholar
• Hoffmann N, Lee B, Hentzer M, Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 2007;51(10):3677-87
   PubMed Web of Science ®Google Scholar
• Tateda K, Comte R, Pechere JC, Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001;45(6):1930-3
   PubMed Web of Science ®Google Scholar
• Carfartan G, Gerardin P, Turck D, Husson MO. Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients. J Antimicrob Chemother 2004;53(4):686-8
   PubMed Web of Science ®Google Scholar
• Ichimiya T, Takeoka K, Hiramatsu K, The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 1996;42(3):186-91
   PubMed Web of Science ®Google Scholar
• Saiman L, Chen Y, Gabriel PS, Knirsch C. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 2002;46(4):1105-7
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Ichimiya T, Hirai K, Effect of antimicrobial agents on the piliation of Pseudomonas aeruginosa and adherence to mouse tracheal epithelium. J Chemother 1997;9(1):32-7
   PubMed Web of Science ®Google Scholar
• Cheung TK, Lam B, Lam KF, Gastroesophageal reflux disease is associated with poor asthma control, quality of life, and psychological status in Chinese asthma patients. Chest 2009;135(5):1181-5
   PubMed Web of Science ®Google Scholar
• Mastronarde JG, Anthonisen NR, Castro M, Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009;360(15):1487-99
   PubMed Web of Science ®Google Scholar
• Kiljander TO, Harding SM, Field SK, Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006;173(10):1091-7
   PubMed Web of Science ®Google Scholar
• Rothenberg SS, Bratton D. The effects of laparoscopic Nissen fundoplication to enhance pulmonary function in the treatment of a patient with severe asthma and gastroesophageal reflux disease. J Allergy Clin Immunol 2008;121(4):1069-70
   PubMed Web of Science ®Google Scholar
• Casanova C, Baudet JS, del Valle Velasco M, Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J 2004;23(6):841-5
   PubMed Web of Science ®Google Scholar
• Mokhlesi B. Clinical implications of gastroesophageal reflux disease and swallowing dysfunction in COPD. Am J Respir Med 2003;2(2):117-21
   PubMedGoogle Scholar
• Rascon-Aguilar IE, Pamer M, Wludyka P, Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006;130(4):1096-101
   PubMed Web of Science ®Google Scholar
• Terada K, Muro S, Sato S, Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 2008;63(11):951-5
   PubMed Web of Science ®Google Scholar
• Blondeau K, Dupont LJ, Mertens V, Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 2008;57(8):1049-55
   PubMed Web of Science ®Google Scholar
• Navarro J, Rainisio M, Harms HK, Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European epidemiologic registry of cystic fibrosis. Eur Respir J 2001;18(2):298-305
   PubMed Web of Science ®Google Scholar
• D'Ovidio F, Singer LG, Hadjiliadis D, Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg 2005;80(4):1254-60
   PubMed Web of Science ®Google Scholar
• Stovold R, Forrest IA, Corris PA, Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med 2007;175(12):1298-303
   PubMed Web of Science ®Google Scholar
• Ward C, Forrest IA, Brownlee IA, Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 2005;60(10):872-4
   PubMed Web of Science ®Google Scholar
• Blondeau K, Mertens V, Vanaudenaerde BA, Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2008;31(4):707-13
   PubMed Web of Science ®Google Scholar
• Davis RD Jr, Lau CL, Eubanks S, Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125(3):533-42
   PubMed Web of Science ®Google Scholar
• Mertens V, Blondeau K, Pauwels A, Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig Dis Sci 2009;54(5):972-9
   PubMed Web of Science ®Google Scholar
• Spahn JD, Fost DA, Covar R, Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. Ann Allergy Asthma Immunol 2001;87(6):501-5
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Rose JQ, Ellis EF, The effect of troleandomycin on methylprednisolone elimination. J Allergy Clin Immunol 1980;66(6):447-51
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Jersmann H, Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178(2):139-48
   PubMed Web of Science ®Google Scholar
• Kumar V, Harjai K, Chhibber S. Effect of clarithromycin on lung inflammation and alveolar macrophage function in Klebsiella penumoniae B5055-induced acute lung infection in BALB/c mice. J Chemother 2008;20(5):609-14
   PubMed Web of Science ®Google Scholar
• Yamaryo T, Oishi K, Yoshimine H, Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother 2003;47(1):48-53
   PubMed Web of Science ®Google Scholar
• Khan AA, Slifer TR, Araujo FG, Remington JS. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 1999;11(2):121-32
   PubMed Web of Science ®Google Scholar
• Amayasu H, Yoshida S, Ebana S, Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000;84(6):594-8
   PubMed Web of Science ®Google Scholar
• Sato E, Nelson DK, Koyama S, Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro. Antimicrob Agents Chemother 2001;45(2):401-6
   PubMed Web of Science ®Google Scholar
• Shoji T, Yoshida S, Sakamoto H, Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. Clin Exp Allergy 1999;29(7):950-6
   PubMed Web of Science ®Google Scholar
• Kadota J, Mizunoe S, Kishi K, Antibiotic-induced apoptosis in human activated peripheral lymphocytes. Int J Antimicrob Agents 2005;25(3):216-20
   PubMed Web of Science ®Google Scholar
• Morikawa K, Zhang J, Nonaka M, Morikawa S. Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production. Int J Antimicrob Agents 2002;19(1):53-9
   PubMed Web of Science ®Google Scholar
• Ogawa N, Sugawara Y, Fujiwara Y, Noma T. Roxithromycin promotes lymphocyte apoptosis in Dermatophagoides-sensitive asthma patients. Eur J Pharmacol 2003;474(2-3):273-81
   PubMed Web of Science ®Google Scholar
• Urasaki Y, Nori M, Iwata S, Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages. J Rheumatol 2005;32(9):1765-74
   PubMed Web of Science ®Google Scholar
• Williams AC, Galley HF, Watt AM, Webster NR. Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother 2005;56(3):502-6
   PubMed Web of Science ®Google Scholar
• Ishida Y, Abe Y, Harabuchi Y. Effects of macrolides on antigen presentation and cytokine production by dendritic cells and T lymphocytes. Int J Pediatr Otorhinolaryngol 2007;71(2):297-305
   PubMed Web of Science ®Google Scholar
• Sugiyama K, Shirai R, Mukae H, Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin Exp Immunol 2007;147(3):540-6
   PubMed Web of Science ®Google Scholar
• Abdelghaffar H, Vazifeh D, Labro MT. Comparison of various macrolides on stimulation of human neutrophil degranulation in vitro. J Antimicrob Chemother 1996;38(1):81-93
   PubMed Web of Science ®Google Scholar
• Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. Mediators Inflamm 2004;13(5-6):313-9
   PubMed Web of Science ®Google Scholar
• Gorrini M, Lupi A, Viglio S, Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics. Am J Respir Cell Mol Biol 2001;25(4):492-9
   PubMed Web of Science ®Google Scholar
• Kawasaki S, Takizawa H, Ohtoshi T, Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob Agents Chemother 1998;42(6):1499-502
   PubMed Web of Science ®Google Scholar
• Vanaudenaerde BM, Wuyts WA, Geudens N, Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007;7(1):76-82
   PubMed Web of Science ®Google Scholar
• Murphy DM, Forrest IA, Ward C, Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts. Thorax 2007;62(9):833
   Web of Science ®Google Scholar
• Murphy DM, Forrest IA, Corris PA, Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells. J Heart Lung Transplant 2008;27(11):1210-6
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Hagiwara K, Honda Y, Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors. J Antimicrob Chemother 2002;49(5):745-55
   PubMed Web of Science ®Google Scholar
• Ivetic Tkalcevic V, Bosnjak B, Hrvacic B, Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. Eur J Pharmacol 2006;539(1-2):131-8
   PubMed Web of Science ®Google Scholar
• Legssyer R, Huaux F, Lebacq J, Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. Respir Res 2006;7:134
   PubMed Web of Science ®Google Scholar
• Jang YJ, Kwon HJ, Lee BJ. Effect of clarithromycin on rhinovirus-16 infection in A549 cells. Eur Respir J 2006;27(1):12-9
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yamaya M, Sekizawa K, Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am J Respir Crit Care Med 2002;165(8):1113-8
   PubMed Web of Science ®Google Scholar
• Parnham MJ, Culic O, Erakovic V, Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. Eur J Pharmacol 2005;517(1-2):132-43
   PubMed Web of Science ®Google Scholar
• Beagley KW, Huston WM, Hansbro PM, Timms P. Chlamydial infection of immune cells: altered function and implications for disease. Crit Rev Immunol 2009;29(4):275-305
   PubMed Web of Science ®Google Scholar
• Chmura K, Bai X, Nakamura M, Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol 2008;295(1):L220-30
   PubMed Web of Science ®Google Scholar
• Hahn DL, Peeling RW. Airflow limitation, asthma, and Chlamydia pneumoniae-specific heat shock protein 60. Ann Allergy Asthma Immunol 2008;101(6):614-8
   PubMed Web of Science ®Google Scholar
• Kohyama T, Yamauchi Y, Takizawa H, Clarithromycin inhibits fibroblast migration. Respir Med 2008;102(12):1769-76
   PubMed Web of Science ®Google Scholar
• Shinkai M, Tamaoki J, Kobayashi H, Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression. Antimicrob Agents Chemother 2006;50(5):1738-44
   PubMed Web of Science ®Google Scholar
• Stamatiou R, Paraskeva E, Boukas K, Azithromycin has an anti-proliferative and autophagic effect on airway smooth muscle cells. Eur Respir J 2009;34(3):721-30
   Google Scholar
• Sasaki M, Ito T, Kashima M, Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro. Mediators Inflamm 2001;10(5):259-67
   PubMed Web of Science ®Google Scholar
• Wada T, Sata M, Sato J, Clarithromycin suppresses invasiveness of human lung adenocarcinoma cells. Chemotherapy 2007;53(2):77-84
   PubMed Web of Science ®Google Scholar
• Sassa K, Mizushima Y, Fujishita T, Therapeutic effect of clarithromycin on a transplanted tumor in rats. Antimicrob Agents Chemother 1999;43(1):67-72
   PubMed Web of Science ®Google Scholar
• Ogawa M, Suzuki J, Hishikari K, Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. J Am Coll Cardiol 2008;51(20):1977-85
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175(4):367-416
   PubMed Web of Science ®Google Scholar
• Newcomb DC, Peebles RS Jr. Bugs and asthma: a different disease? Proc Am Thorac Soc 2009;6(3):266-71
   PubMedGoogle Scholar
• Forrest IA, Murphy DM, Ward C, Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J 2005;26(6):1080-5
   PubMed Web of Science ®Google Scholar
• Cosentini R, Tarsia P, Canetta C, Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res. 2008;9:48
   PubMed Web of Science ®Google Scholar
• Yalcin E, Kiper N, Ozcelik U, Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. J Clin Pharm Ther 2006;31(1):49-55
   PubMed Web of Science ®Google Scholar
• Ou XM, Feng YL, Wen FQ, Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB. Respirology 2008;13(1):63-72
   PubMed Web of Science ®Google Scholar
• Morinaga Y, Yanagihara K, Miyashita N, Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. Pulm Pharmacol Ther 2009;22(6):580-6
   Google Scholar
• Mizunoe S, Kadota J, Tokimatsu I, Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol 2004;4(9):1201-7
   PubMed Web of Science ®Google Scholar
• Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J 2004;23(5):671-8
   PubMed Web of Science ®Google Scholar
• Fost DA, Leung DY, Martin RJ, Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. J Allergy Clin Immunol 1999;103(6):1031-5
   PubMed Web of Science ®Google Scholar